Skip to main content
Log in

Evaluation of the brain, renal, and hepatic effects of flunixin meglumine, ketoprofen, and phenylbutazone administration in Iranian fat-tailed sheep

  • SI Fat Tailed Sheep
  • Published:
Tropical Animal Health and Production Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to evaluate the brain, renal, and hepatic effects of three NSAIDs (flunixin meglumine, ketoprofen, and phenylbutazone) when administered IV to clinically normal Iranian fat-tailed sheep.

Methods

The experiments were conducted on twenty clinically normal adult female sheep. Sheep were randomly assigned to four groups: saline (n = 5), flunixin meglumine (n = 5), ketoprofen (n = 5), and phenylbutazone (n = 5). Drug administration was initiated at 8 am on day 1 and continued every 12 h for 12 days. Flunixin meglumine, ketoprofen, and phenylbutazone were administered at dose rate of 2.2, 4, and 4 mg/kg, respectively. Daily blood and urine samples were collected from all sheep for hematologic, enzymes activity, and urinalysis. Immediately after euthanasia, complete necropsy was performed on all sheep and gross lesions were recorded.

Results

Clinical, hematological, serum, and urine analysis and histopatholgical findings were described.

Conclusion

When the use of these compounds is contemplated in clinical cases, the risk of adverse effects and the comparative toxic potential should be considered, along with the efficacy of the compound for the condition being treated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Burrows, G.E. 1981. Therapeutic effect of phenylbutazone on experimental acute Escherichia coli endotoxemia in ponies. American Journal of Veterinary Research, 42(1), 94–99.

    PubMed  CAS  Google Scholar 

  • Burtis, C.A. & Ashwood, E.R. 1994. Tietz Textbook of Clinical Chemistry 2nd ed. WB Saunders.

  • Carmichael, J. & Shankel, S.W. 1985. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. The American Journal of Medicine, 78(6 Pt 1), 992–1000.

    Article  PubMed  CAS  Google Scholar 

  • Clive, D.M. & Stoff, J.S. 1984. Renal syndromes associated with nonsteroidal antiinflammatory drugs. The New England Journal of Medicine, 310, 563–572.

    Article  PubMed  CAS  Google Scholar 

  • Dunkle, N.J., Bottoms, G.D., Fessler, J.F., Knox, K. & Roesel, O.F. 1985. Effects of flunixin meglumine on blood pressure and fluid compartment volume changes in ponies given endotoxin. American Journal of Veterinary Research, 46(7), 1540–1544.

    PubMed  CAS  Google Scholar 

  • Fessler, J.F., Bottoms, G.D., Roesel, O.F., Moore, A.B., Frauenfelder, H.C. & Boon, G.D. 1982. Endotoxin-induced change in hemograms, plasma enzymes, and blood chemical values in anesthetized ponies: effects of flunixin meglumine. American Journal of Veterinary Research (USA), 43(1), 140–144.

    CAS  Google Scholar 

  • Gunson, D.E. 1983. Renal papillary necrosis in horses. Journal of the American Veterinary Medical Association, 182(3), 263–266.

    PubMed  CAS  Google Scholar 

  • Houdeshell, J.W. & Hennessey, P.W. 1977. A new non-steroidal, anti-inflammatory analgesic for horses. Journal of Equine Medicine and Surgery, 1, 57–63.

    CAS  Google Scholar 

  • Insel, P.A. 1990. Analgesic-antipyretics and Anti-inflammatory Agents: Drugs Employed in the Treatment of Rheumatoid Arthritis and Gout. Pergamon Press, New York.

    Google Scholar 

  • Kari, F., Bucher, J., Haseman, J., Eustis, S. & Huff, J. 1995. Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice. Japanese Journal of Cancer Research, 86(3), 252–263.

    PubMed  CAS  Google Scholar 

  • Lees, P. & Higgins, A.J. 1987. Physiological, biochemical and haematological effects on horses of a phenylbutazone paste. The Veterinary Record, 121(3), 56–60.

    Article  PubMed  CAS  Google Scholar 

  • MacAllister, C.G., Morgan, S.J., Borne, A.T. & Pollet, R.A. 1993. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. Journal of the American Veterinary Medical Association (USA), 202(1), 71–77.

    CAS  Google Scholar 

  • Manoukian, A.V. & Carson, J.L. 1996. Nonsteroidal anti-inflammatory drug-induced hepatic disorders: Incidence and prevention. Drug Safety, 15(1), 64–71.

    Article  PubMed  CAS  Google Scholar 

  • Meschter, C.L., Gilbert, M., Krook, L., Maylin, G. & Corradino, R. 1990. The effects of phenylbutazone on the intestinal mucosa of the horse: a morphological, ultrastructural and biochemical study. Equine Veterinary Journal (United Kingdom), 22, 255–263.

    CAS  Google Scholar 

  • Moore, J.N., Garner, H.E., Shapland, J.E. & Hatfield, D.G. 1981. Prevention of endotoxin-induced arterial hypoxaemia and lactic acidosis with flunixin meglumine in the conscious pony. Equine Veterinary Journal, 13(2), 95–98.

    Article  PubMed  CAS  Google Scholar 

  • Moore, J.N., Hardee, M.M. & Hardee, G.E. 1986. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor. American Journal of Veterinary Research, 47(1), 110–113.

    PubMed  CAS  Google Scholar 

  • Mozaffari, A.A., Safarchi, R., Derakhshanfar, A. & Marvili, O.A. 2010. Evaluation of the Effects of Flunixin Meglumine, Ketoprofen and Phenylbutazone Administration on the Brain, Renal and Hepatic Functions in Iranian Cross-Breed Goats. Journal of Biological Sciences, 10(2), 170–173.

    Article  Google Scholar 

  • Read, W.K. 1983. Renal medullary crest necrosis associated with phenylbutazone therapy in horses. Veterinary Pathology, 20(6), 662–669.

    Article  PubMed  CAS  Google Scholar 

  • Reilly, J.S. 2001. Euthanasia of animals used for scientific purposes ANCCART, Adelaide.

  • Snow, D.H., Bogan, J.A., Douglas, T.A. & Thompson, H. 1979. Phenylbutazone toxicity in ponies. The Veterinary Record, 105(2), 26–30.

    Article  PubMed  CAS  Google Scholar 

  • Tobin, T., Chay, S., Kamerling, S., Woods, W.E., Weckman, T.J., Blake, J.W. & Lees, P. 1986. Phenylbutazone in the horse: a review. Journal of Veterinary Pharmacology and Therapeutics, 9(1), 1–25.

    Article  PubMed  CAS  Google Scholar 

  • Traub-Dargatz, J.L., Bertone, J.J., Gould, D.H., Wrigley, R.H., Weiser, M.G. & Forney, S.D. 1988. Chronic flunixin meglumine therapy in foals. American Journal of Veterinary Research, 49(1), 7–12.

    PubMed  CAS  Google Scholar 

  • Vane, J.R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature: New Biology, 231(25), 232–235.

    CAS  Google Scholar 

  • Vernimb, G.D. & Hennessey, P.W. 1977. Clinical studies on flunixin meglumine in the treatment of equine colic. Joural of Equine Medical Surgury, 1, 111–116.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Asghar Mozaffari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mozaffari, A.A., Derakhshanfar, A. Evaluation of the brain, renal, and hepatic effects of flunixin meglumine, ketoprofen, and phenylbutazone administration in Iranian fat-tailed sheep. Trop Anim Health Prod 43, 1389–1393 (2011). https://doi.org/10.1007/s11250-011-9866-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11250-011-9866-5

Keywords

Navigation